Ovarian cancer, often a \"silent killer,\" is the 8th most common cancer in women globally and the third in India. Early ...

Initial findings from the Every Woman Study™: Low- and Middle-Income Countries is published in The Lancet Obstetrics, ...

A Los Angeles Superior Court jury deliberated for one day before awarding $40 million, all compensatory damages, to two women ...

A California jury awarded $40 million to two women who said Johnson & Johnson’s talc-based baby powder caused their ovarian ...

A Los Angeles Superior Court jury is expected to begin deliberations Friday in a closely watched trial that involves two ...

Hua-Ying Fan, PhD, hopes that her team's latest discovery could help the almost 21,000 people who are expected to receive an ...

Ovarian cancer tends to be resistant to hormone therapy, even when it should theoretically respond. Wistar Institute ...

A California jury awarded $40 million to two women after blaming Johnson & Johnson's baby powder for their ovarian cancer. The jury found that J&J knew its talc products were dangerous but failed to ...

The use of hormone replacement therapy (HRT) does not have an adverse effect on breast cancer risk according to results from ...

Suze Lopez, a 41-year-old nurse from Bakersfield, was scheduled to have a 22-pound ovarian cyst removed but then discovered that she was pregnant.

Ovarian01 Phase 3 Trial of ENHERTU® Initiated as First-Line Maintenance Therapy in Patients with HER2 Expressing Advanced ...

Philadelphia, PA, USA, December 9, 2025, First Patient Enrolled in GOG-3133/ FRAmework-01 Phase 3 Study Evaluating Sofetabart ...